Therapeutic Potential of Carboxytherapy and Its Impact on the Pathogenesis and Symptoms of Covid-19

Abstract

Corona virus disease (COVID-19) is an infectious disease caused by the SARS-CoV-2 virus and its mutants. COVID-19 is often the cause of the development of pathologies on the part of the respiratory system against the background of hypoxia. One of the alternative methods of eliminating hypoxia is carboxytherapy, since carbon dioxide (CO2) has an anti-hypoxic, antioxidant effect due to its physiological properties. The use of CO2 in the treatment can be effective in eliminating the symptoms of pleuropulmonary pathology, as CO2 has anti-inflammatory, antiviral and antimicrobial effects.